Nausea, vomiting, loss of appetite, diarrhea, stomach pain, headache, dizziness, drowsiness, depression, anxiety, or skin irritation at the application site may occur. If you have Parkinson's disease, its symptoms may worsen, especially shaking (tremors). If any of these effects persist or worsen, contact your doctor or pharmacist promptly.
Remember that your doctor has prescribed this medication...
Read moreYesterday, the FDA approved the first skin patch version of Exelon, a drug to treat mild or moderate dementia in patients with Alzheimer's.... Read more »
On Monday, Novartis, a pharmaceutical giant, received U.S. approval for the Exelon Patch, which delivers a treatment for Alzheimer's... Read more »
A study done by researchers at the University of Montreal suggests that sleep deprivation triggers sleepwalking. The researchers studied... Read more »
In a recent court case in the Northern Territory of Australia, Leonard Andrew Spencer was found not guilty of gross indecency and having... Read more »
The FDA has approved Butrans™ (buprenorphine) Transdermal System CIII for the management of moderate to severe chronic pain in patients... Read more »
The first skin patch to deliver medication to Alzheimer's patients could be available soon, a researcher reports. The patch, which delivers the... Read more »
This is a study to evaluate the safety of switching from Aricept to an Exelon patch in patients with Alzheimer's disease. This national study is... Read more »
This is a study to determine the safety and tolerability of switching from Aricept to the Exelon patch in patients with probable Alzheimer's disease.... Read more »
Source: Harvard Decision Guide
What Is It? A person who is sleepwalking walks or makes other movements that seem purposeful in a state of partial wakefulness from deep... Read more »
Source: First DataBank
Generic Name: RIVASTIGMINE SOLUTION - ORAL Pronounced: (riv-uh-STIG-meen) Side Effects Nausea, vomiting, stomach pain, loss of appetite,... Read more »